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ejection fraction changed in a negative direction in patients of
ADHF who are troponin positive.
Though from the present study, we got some positive directions
in making prognostic correlation of ADHF patients with troponin
positivity, further large prospective randomized trials are neces-
sary before coming to definite conclusion in making recommen-
dation for doing quantitative troponin T in all patients of acute
decompensated heart failure for prognosis and guiding therapy.
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Background: Heart disease is a frequent complication of chronic
kidney disease and the major cause of death in patients on renal
replacement therapy. The purpose of this study was to evaluate
the impact of successful renal transplantation on systolic and
diastolicventricular dysfunction and pulmonary arterial hyper-
tension in patients with chronic kidney disease (CKD).
Methods: The study included 35 patients >18 years of age with
CKD who had successful kidney transplantations. Ventricular
function and pulmonary arterial pressure were evaluated by
echocardiography before and 1 year after transplant.
Results: The mean age of subjects was 40 _+ 14 years, and 63%
were men. Mean left ventricular ejection fraction (LVEF) was 52 +_
16%. Before transplant, 28 (80%) of the patients had ventricular
dysfunction (34.3% diastolic and 45.7% systolic). Pulmonary arte-
rial hypertension was found in 48.6%. Ventricular dysfunction
was associated with dialysis of >2 years duration before trans-
plant. The LVEF of the entire group increased from 52% to 64% (P <
.001) by 12 months after kidney transplant. Left ventricular di-
ameters, wall thickness, and pulmonary arterial systolic pressure
decreased significantly after transplantation Echocardiograms
became normal 1 year after transplant in 8 (66.7%) of the patients
with diastolic dysfunction and 9 (56.2%) with systolic dysfunction,
and diastolic dysfunction persisted in 5 (31.2%).
Conclusions: Renal transplantation has led to considerable
improvement in left ventricular systolic and diastolic function as
well as pulmonary arterial pressure of patients with CKD, optimal
treatment for dysfunction and transplant as soon as possible is
recommended.
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Background: Abnormal Echocardiographic parameters are seen in
all patients starting dialysis therapy and are associated with the
development of cardiac failure and death.
Objective: to know whether regression of cardiac abnormalities is
associated with an improvement in prognosis with vigorous renal
dialysis.
Methods: As part of a prospective cohort study with mean follow-
up of 6 mo, 57 patients had echocardiography at inception and
after 1 week of vigorous renal dialysis therapy.
Results: Improvements in left ventricular (LV)mass index, volume
index, and fractional shortening were seen in 48, 48, and 46%,
respectively. Twenty-four patients had developed cardiac failure
by 6 months of dialysis therapy. Twenty-six percent of the
remaining 27 patients subsequently developed new-onset cardiac
failure. The mean changes in LV mass index were 17 g/m(2) in
those who subsequently developed cardiac failure compared with
0 g/m(2) among those who did not (P ¼ 0.05). The corresponding
values were -8 versus 0% for fractional shortening (P < 0.0001).
Conclusion: Regression of LV abnormalities is associated with an
improved cardiac outcome in endstage renal disease patients on
vigorous dialysis.
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Background: There are no contemporary data on etiologies,
management and outcomes of heart failure in India. To determine
etiologies andmanagement of heart failure in hospital- and clinic-
based patients in India we performed a study.
Methods: Successive patients presenting to a tertiary care non-
government hospital with acute decompensated heart failure
(ADHF, n¼102) and stable heart failure (SHF, n¼179) were enrolled.
Both the groups were followed for 90 days. Etiology of heart failure
was diagnosed using clinical examination and echocardiography.
Details of in-hospital, discharge and 90-day medications were
obtained in both groups. Outcomes (mortality) data were recor-
ded. Descriptive statistics are reported.
Results: Prevalence of various cardiovascular diseases in ADHF vs
SHF patients, respectively, was coronary heart disease 50.0 vs
53.6%, hypertension 60.8 vs 44.7%, cardiomyopathy 16.7vs 7.3%,
rheumatic heart disease 4.9 vs 14.0%, and hypertrophic cardio-
myopathy 1.0 vs 7.3%. Heart failure with normal ejection fraction
was in 23 ADHF and 2 SHF patients. In-hospital treatments
included diuretics, nitrates, angiotensin converting enzyme (ACE)
inhibitors, digoxin, anticoagulants and vasopressors. At discharge
significantly greater number of patients with ADHF vs SHF were
on loop-diuretics (95.5 vs 78.2%), anti-platelets (74.4 vs 64.2%) and
anti-arrhythmics (23.3 vs 6.1%) while lesser were on thiazides (1.5
vs 9.5%), anti-aldosterone (33.4 vs 43.0%), ACE inhibitors (30.0 vs
35.2%), angiotensin receptor blockers (ARBs, 4.5 vs 40.8%) and
beta-blockers (33.4 vs 45.8%) (p<0.05). Use of digoxin {28.9 vs
31.8%), nitrates (32.2 vs 30.7%) and anticoagulants (11.1 vs 8.9%)
was similar. At 90 days, in ADHF vs SHF patients lower use of ACE
inhibitors (42.4 vs00.0%) and ARBs (4.5 vs. 0.0%) and similar use of
beta-blockers (48.5 vs00.0%) was observed. In ADHF patients, in-
hospital mortality was 10.3% (n¼11). Cumulative 90-day mortality
in ADHF was 45.0% (n¼46) while in SHF patients was 1.1% (n¼7)
(p<0.05).
Conclusions: This study shows that coronary and hypertensive
heart diseases are important causes of heart failure at a tertiary-
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) s 1es 1 4 3S86
